| Kernpublicaties |
-
Glycolytic activity in human immune cells: inter-individual variation and functional implications during health and diabetes
Frank Vrieling, Xanthe A.M.H. van Dierendonck, Martin Jaeger, Anna W.M. Janssen, Anneke Hijmans, Mihai G. Netea, Cees J. Tack, Rinke Stienstra (2022)
Immunometabolism (Cobham)
-
Oxidized low-density lipoprotein (oxLDL) supports Mycobacterium tuberculosis survival in macrophages by inducing lysosomal dysfunction
Frank Vrieling, Louis Wilson, Patrick C. N. Rensen, Gerhard Walzl, Tom H. M. Ottenhoff, Simone A. Joosten (2019)
PLoS Pathogens
-
Patients with Concurrent Tuberculosis and Diabetes Have a Pro-Atherogenic Plasma Lipid Profile
Frank Vrieling, Katharina Ronacher, Léanie Kleynhans, Erik van den Akker, Gerhard Walzl, Tom H.M. Ottenhoff, Simone A. Joosten (2018)
EBioMedicine
-
Plasma metabolomics in tuberculosis patients with and without concurrent type 2 diabetes at diagnosis and during antibiotic treatment
Frank Vrieling, Bachti Alisjahbana, Edhyana Sahiratmadja, Reinout van Crevel, Amy C. Harms, Thomas Hankemeier, Tom H. M. Ottenhoff & Simone A. Joosten (2019)
Scientific Reports
-
Analyzing the impact of Mycobacterium tuberculosis infection on primary human macrophages by combined exploratory and targeted metabolomics
Frank Vrieling, Sarantos Kostidis, Herman P. Spaink, Mariëlle C. Haks, Oleg A. Mayboroda, Tom H. M. Ottenhoff & Simone A. Joosten (2020)
Scientific Reports
|
|